MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.

TSXV:MIR - Post by User

MedMira Inc > MIR news update

<< Previous

Bullboard Posts

Next >>

Comment by Eamp4840on Dec 30, 2020 10:08pm

147 Views

Post# 32201157

RE:MIR news update

From the news release : "As a result, and in consultation with our partners, MedMira decided to move forward with a simple solution by launching REVEALCOVID-19(TM) PLUS Total Antibody," said Hermes Chan, CEO of MedMira Inc. "This shall enable us to introduce the new product version and address the additional market demands, focussing our attention on the production of 50,000 units of REVEALCOVID-19T PLUS Total Antibody Test daily. This will position MedMira as a major contender in the coming months, as the vaccines are now being administered globally. The knowledge gained during the original EUA application has been invaluable.""

50k units daily ???

<< Previous

Bullboard Posts

Next >>

Gold begins to flow at Endeavour's Lafigué mine in Côte d'Ivoire